1 / 9

Life Sciences Panel Discussion

Life Sciences Panel Discussion. April 5-6, 2018 Fordham University Stephane Drouin. UCB’s proposition. Creating value for patients. Shifting the IP paradigm. UCB’s IP proposition. Public Perception. UCB. Streamlining our patent portfolio has helped UCB to focus on CORE INNOVATION:.

kory
Télécharger la présentation

Life Sciences Panel Discussion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Life Sciences Panel Discussion • April 5-6, 2018 Fordham University • Stephane Drouin

  2. UCB’s proposition Creating value for patients

  3. Shifting the IP paradigm UCB’s IP proposition Public Perception UCB

  4. Streamlining our patent portfolio has helped UCB to focus on CORE INNOVATION: Innovation that makes a tangible difference to patients

  5. UCB’s ‘core innovation’ proposition What it means and how it differs - 25 % Patient-centric medicine providing access and sustainable healthcare meeting patient needs Pushing our company to find the right drug for the right patient Make the linkbetween value wecreate and whatweprotect

  6. Patents are not the goal… …DELIVERING PATIENT SOLUTIONS IS.

  7. Thanks!

  8. Pat-INFORMED Database Patent Information Initiative for Medicines (Pat-INFORMED) • Joint IFPMA and WIPO initiative announced at WIPO General Assembly (10/2017). • Aims to enhance the reputation of intellectual property as a foundation of global healthcare. • Welcomed by WHO, the Gates Foundation, the Medicines Patent Pool and many member states. • UCB and more than 20 other companies committed to make global patent information, similar to the US “Orange book”, on medicines available via Pat-INFORMED. • Initial database covers granted patents for small molecule products within oncology, hepatitis C, cardiovascular, HIV, diabetes, respiratory therapy areas, and any products on the WHO Essential Medicines List.

More Related